COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 2071: Articles 20701-20710  | Next

Real-life performances of a novel antigen detection test on nasopharyngeal specimens for SARS-CoV-2 infection diagnosis: a prospective study
Courtellemont, L., Guinard, j., Guillaume, C., Giache, S., Rzepecki, V., Seve, A., Gubavu, C., Baud, K., Doize, H., Le Helloco, C., Lebegue, C., Tay, E. A., Cassuto, G., Pialoux, G., Hocqueloux, L., prazuck, t.
10.1101/2020.10.28.20220657 — Posted: 2020-11-03
Liquid chalk is an antiseptic against SARS-CoV-2 and influenza A respiratory viruses
McAuley, J. L., Deerain, J. M., Hammersla, W., Aktepe, T. E., Purcell, D. J. F., Mackenzie, J.
10.1101/2020.11.02.364661 — Posted: 2020-11-02
Ivermectin reduces coronavirus infection in vivo: a mouse experimental model
Arevalo, A. P., Pagotto, R., Porfido, J., Daghero, H., Segovia, M., Yamasaki, K., Varela, B., Hill, M., Verdes, J. M., Duhalde Vega, M., Bollati-Fogolin, M., Crispo, M.
10.1101/2020.11.02.363242 — Posted: 2020-11-02
Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
Zuo, J., Dowell, A., Pearce, H., Verma, K., Long, H., Begum, J., Aiano, F., Amin-Chowdhury, Z., Hallis, B., Stapley, L., Borrow, R., Linley, E., Ahmad, S., Parker, B., Horsley, A., Amirthalingam, G., Brown, K., Ramsay, M. E., Ladhani, S., Moss, P.
10.1101/2020.11.01.362319 — Posted: 2020-11-02 Discussion: Onsite | Offsite
Association between living with children and outcomes from COVID-19: an OpenSAFELY cohort study of 12 million adults in England
Forbes, H., Morton, C. E., Bacon, S., McDonald, H. I., Minassian, C., Brown, J., Rentsch, C. T., Mathur, R. T., Schultze, A., DeVito, N. J., MacKenna, B., Hulme, W. J., Croker, R., Walker, A. J., Williamson, E. J., Bates, C., Mehrkar, A., Curtis, H. J., Evans, D., Wing, K., Inglesby, P., Drysdale, H., Wong, A., Cockburn, J., Mcmanus, R., Parry, J., Hester, F., Harper, S., Douglas, I. J., Smeeth, L., Evans, S. J., Bhaskaran, K., Eggo, R. M., Goldacre, B., Tomlinson, L.
10.1101/2020.11.01.20222315 — Posted: 2020-11-02 Discussion: Onsite | Offsite
Characterization of structural and energetic differences between conformations of the SARS-CoV-2 spike protein
Moreira, R. A., Guzman, H. V., Boopathi, S., Baker, J. L., Poma, A. B.
10.1101/2020.11.01.363499 — Posted: 2020-11-02
Genetic diversity analysis of the D614G mutation in SARS-CoV-2
Felix, P. T., Silva, E. D. A. B., Venancio, D. B. R., Ramos, R. d. S.
10.1101/2020.10.30.362954 — Posted: 2020-11-02
D614G substitution enhances the stability of trimeric SARS-CoV-2 spike protein
Yazhini, A., Sidhanta, D. S. P., Srinivasan, N.
10.1101/2020.11.02.364273 — Posted: 2020-11-02
Temporal patterns in the evolutionary genetic distance of SARS-CoV-2 during the COVID-19 pandemic
Lou, J., Zhao, S., Cao, L., Chen, Z., Chan, R. W., Chong, M. K., Zee, B. C., Chan, P. K., Wang, M. H.
10.1101/2020.11.01.363739 — Posted: 2020-11-02
Photocatalyst under visible light irradiation inactivates SARS-CoV-2 on an abiotic surface
Uema, M., Yonemitsu, K., Momose, Y., Ishii, Y., Tateda, K., Inoue, T., Asakura, H.
10.1101/2020.11.01.364364 — Posted: 2020-11-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).